Silvercrest Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-87,050
Closed -$3.62M 863
2021
Q2
$3.62M Buy
87,050
+10,520
+14% +$421K 0.02% 433
2021
Q1
$2.82M Buy
76,530
+20
+0% +$756 0.02% 449
2020
Q4
$3.18M Buy
76,510
+15,835
+26% +$660K 0.02% 417
2020
Q3
$2.58M Buy
60,675
+22,170
+58% +$956K 0.02% 433
2020
Q2
$1.67M Sell
38,505
-3,620
-9% -$143K 0.01% 475
2020
Q1
$1.38M Buy
42,125
+11,775
+39% +$438K 0.01% 466
2019
Q4
$1.12M Buy
30,350
+75
+0.2% +$2.66K 0.01% 519
2019
Q3
$1.02M Buy
30,275
+2,405
+9% +$85.2K 0.01% 528
2019
Q2
$1.09M Buy
+27,870
New +$1.1M 0.01% 374
2013
Q4
Sell
-31,190
Closed -$1.01M 465
2013
Q3
$1.01M Sell
31,190
-34,730
-53% -$1.13M 0.02% 303
2013
Q2
$2.33M Buy
+65,920
New +$2.29M 0.05% 229

Other funds holding FMS

Silvercrest Asset Management's FMS Position: Q3 2021 in Review

Silvercrest Asset Management sold out of Fresenius Medical Care (FMS) in Q3 2021, closing a stake of 87,050 shares — an estimated $3.62M sold.

Silvercrest Asset Management first reported a position in FMS in Q2 2013 and held it in 11 quarters. The position peaked at $3.62M in Q2 2021. 159 funds tracked by Wall St. Rank hold FMS as of Q3 2021.

  • Silvercrest Asset Management reported no remaining Fresenius Medical Care position as of Q3 2021 after selling out during the quarter.
  • Silvercrest Asset Management sold 87,050 Fresenius Medical Care shares in Q3 2021, an estimated $3.62M.
  • Silvercrest Asset Management first reported a position in Fresenius Medical Care in Q2 2013 and held it in 11 quarters.
  • Silvercrest Asset Management's Fresenius Medical Care position peaked at $3.62M in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2021.

Based on Silvercrest Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.